Author

Josien Jonker

Observed names: J Jonker, Jonker, Josien

Institution: GGZ Drenthe

Observed institutions: University Medical Center Groningen, University of Groningen, GGZ Drenthe

ORCID: 0000-0002-7913-2967

Observed ORCID: 0000-0002-7913-2967

OpenAlex ID: A5071436631

A survey on service users' perspectives about information and shared decision‐making in psychotropic drug prescriptions in people with intellectual disabilities

2024 · Gerda de Kuijper, Josien Jonker, et al. · British Journal of Learning Disabilities · 11

Challenging behaviour, the application of restrictive measures and psychotropic drug prescription in people with intellectual disabilities

2024 · Josien Jonker, Sytse Ulbe Zuidema, et al. · Research in Developmental Disabilities · 5

Structured Medication Review and Shared Decision-Making in Patients with Mild Intellectual Disabilities Who Use Psychotropic Medication

2026 · Gerda de Kuijper, Josien Jonker, et al. · Pharmacy · 4

Integrative Care for Challenging Behaviors in People with Intellectual Disabilities to Reduce Challenging Behaviors and Inappropriate Psychotropic Drug Prescribing Compared with Care as Usual: A Cluster-Randomized Trial

2024 · Gerda de Kuijper, Josien Jonker, et al. · International Journal of Environmental Research and Public Health · 3

Off‐Label Antipsychotic Withdrawal in People With Intellectual Disabilities: Development and Internal Validation of a Prediction Model

2025 · Joëlle Weijgertze‐Lanser, Maureen B. G. Wissing, et al. · Journal of Intellectual Disability Research · 1

Developing and testing of an assessment tool for appropriate psychotropic drug prescribing in people with intellectual disabilities

2025 · Josien Jonker, Gerda Margaretha de Kuijper, et al. · Therapeutic Advances in Drug Safety · 1

Improving Descriptive Diagnostics of Autism in People With Moderate or Severe Intellectual Disabilities: A Qualitative Participatory Study

2026 · Annelies de Bildt, Josien Jonker, et al. · Journal of Autism and Developmental Disorders

Experiences with shared decision-making in psychotropic medication for people with intellectual disabilities: perspectives of experts by experience, relatives, and support professionals

2026 · Josien Jonker, Gerda de Kuijper, et al. · Frontiers in Psychiatry

[Dilemmas in discontinuation of antipsychotic drug use in people with intellectual disabilities].

2020 · G de Kuijper, L Ramerman, et al. · PubMed

Works count: 10

Citation count: 25

H-index: 3

I10-index: 1